STOP Scleroderma

The Scleroderma bioreposiTOry and Pathogenesis Study (STOP Scleroderma) will help researchers use clinical data and human biospecimens to investigate why scleroderma patients develop certain complications from their disease. Patients with confirmed scleroderma, raynauds or positive autoantibodies are invited to participate. This research may help us understand how to prevent and treat scleroderma and other diseases.

Sponsor(s)
None
Principal Investigator(s)
Victoria Shanmugam/Rheumatology
Request Information
Address

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

1 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.